GC2302 Study Site 101 — Garner, North Carolina

GC2302 Study Site 101 is a clinical research site located in Garner, North Carolina, United States 27529.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2302 Study Site 101 has participated in 1 clinical trials.

Therapeutic areas: Dry Eye Disease.

Sponsors: Instituto Grifols, S.A..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Garner

Browse all research sites in North Carolina · View every site in Garner

• Oculus Research
• UNC Health Cancer Care Garner
• Rex Hematology Oncology Associates-Garner
• Novo Nordisk Investigational Site
• WakeMed Garner Hlthplx
• Pfizer Investigational Site
• Visus Therapeutics Investigative Site
• Sylentis Investigative Site
• RHOA of Garner
• United States, North Carolina
• Clinical Site 15
• UNC Rex Hematology Oncology Associates of Garner

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2302 Study Site 101?

GC2302 Study Site 101 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2302 Study Site 101 conducted?

GC2302 Study Site 101 has 1 clinical trials on record. Their work covers Dry Eye Disease.

Is GC2302 Study Site 101 accredited by Crixeo Clinical Trials?

GC2302 Study Site 101 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2302 Study Site 101?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.